Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by EquityInveston May 15, 2018 10:04pm
62 Views
Post# 28036545

RE:RE:RE:RE:Question: ACB & CRON

RE:RE:RE:RE:Question: ACB & CRONThe timing of the impairment charge off the Goodwill is subject to market "assessment" of the reasonableness of the carrying value of the goodwill.  We do not "amortize" Goodwill over a period of time, rather it is annually assessed.  If ACB does not execute well, the overpayment made to LEAF will be impaired.

herewegobigboii wrote: why do you think they'll have an impairment charge on the goodwill? Impairment of goodwill requires the company to compare value in use (discounted future cash flows), and fair value less costs to sell.  Value in use is based on estimates of future cash flows. Based off of general market predictions for the MJ sector, sales are going to grow quite quickly over the next decade.  Given that information, and the subjectivity required in recording a goodwill impairment...how do you figure they'll do take an impairment on goodwill any time soon?


Bullboard Posts